Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

@article{McNeil2014InterimEO,
  title={Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.},
  author={S. McNeil and V. Shinde and M. Andrew and T. Hatchette and J. Leblanc and A. Ambrose and G. Boivin and W. Bowie and F. Diaz-Mitoma and M. Elsherif and K. Green and F. Haguinet and S. Halperin and B. Ibarguchi and K. Katz and J. Langley and P. Lagacé-Wiens and B. Light and M. Loeb and J. Mcelhaney and D. MacKinnon-Cameron and A. McCarthy and M. Poirier and J. Powis and D. Richardson and M. Semret and S. Smith and D. Smyth and G. Stiver and S. Trottier and L. Valiquette and D. Webster and L. Ye and A. McGeer},
  journal={Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin},
  year={2014},
  volume={19 9}
}
  • S. McNeil, V. Shinde, +31 authors A. McGeer
  • Published 2014
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
During the 2013/14 influenza season in Canada, 631 of 654 hospitalisations for laboratory-confirmed influenza enrolled in sentinel hospitals were due to Influenza A. Of the 375 with known subtype, influenza A(H1N1) accounted for 357. Interim unmatched vaccine effectiveness adjusted for age and presence of one or more medical comorbidities was determined by test-negative case-control design to be 58.5% (90% confidence interval (CI): 43.9-69.3%) overall and 57.9% (90% CI: 37.7-71.5) for confirmed… Expand
Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014.
  • N. Turner, N. Pierse, +4 authors H. Kelly
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2014
Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.
  • F. Havers, L. Sokolow, +13 authors A. Fry
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2016
...
1
2
3
4
...

References

SHOWING 1-10 OF 25 REFERENCES
Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.
Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.
  • D. Skowronski, C. Chambers, +14 authors Y. Li
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2014
Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June - 31 December 2009.
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
  • E. Kissling, M. Valenciano, +14 authors A. Moren
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2014
Hospitalization in two waves of pandemic influenza A(H1N1) in England
...
1
2
3
...